Development
Silo Pharma, Inc.
SILO
$0.5983
-$0.0411-6.43%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -27.23% | -213.18% | -199.54% | -200.12% | -179.34% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.10% | 104.10% | 106.09% | 107.03% | 105.94% |
| Change in Net Operating Assets | 275.86% | 9,855.26% | 1,057.67% | -110.33% | -187.34% |
| Cash from Operations | 5.47% | -35.21% | -23.77% | -53.54% | -65.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,066.07% | -236.41% | -182.73% | -98.79% | -93.64% |
| Cash from Investing | -2,066.07% | -236.41% | -182.73% | -98.79% | -93.64% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -87.30% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.60% | -- | 205,970.83% | 30.23% | 30.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -705.20% | -287.10% | -199.33% | -82.43% | -76.88% |